Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00222742 · ClinicalTrials.gov registry record · Phase 3
Hypothermia in Children After Trauma
A Phase 3 study, sponsored by Phoenix Children's Hospital.
- Terminated
- Registry status
- Phase 3
- Development phase
- 90
- Enrollment target
NCT00222742 is a Phase 3 study that was terminated before completion, run by Phoenix Children's Hospital. The registered enrollment target is 90 participants.
The verdict
NCT00222742, a Phase 3 study, was terminated before completion, sponsored by Phoenix Children's Hospital.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 90 participants
- Enrollment target
Study Summary
The primary hypothesis for this application for a multicenter phase III randomized clinical trial (RCT) is that induced moderate hypothermia (HYPO) (32-33 °C) after severe traumatic brain injury (TBI) in children and maintained for 48 hours will improve mortality at 3 months and 12 month functional outcome as assessed by the Glasgow Outcome Scale (GOS).
Interventions
- PROCEDURE induced moderate hypothermia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2007-11 |
| Est. Completion | 2012-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00222742
The ClinicalTrials.gov registry entry for NCT00222742 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which induced moderate hypothermia is the first listed.
NCT00222742 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00222742 about?
NCT00222742 is a clinical study titled "Hypothermia in Children After Trauma". The primary hypothesis for this application for a multicenter phase III randomized clinical trial (RCT) is that induced moderate hypothermia (HYPO) (32-33 °C) after severe traumatic brain injury (TBI) in children and maintained for 48 hours will improve mortality at 3 months and 12 month functional ...
What is the current status of trial NCT00222742?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 90 participants. The study started on 2007-11. Estimated completion is 2012-03.
What interventions are being tested in trial NCT00222742?
The interventions under investigation include: induced moderate hypothermia (PROCEDURE).
Who is sponsoring clinical trial NCT00222742?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.